Guess what? Those Brain C-13 Review increasing co-pays for brand-name drugs don't exactly thrill the insurance industry either. And pharmacies have a much lower profit margin with brand-name drugs versus profitable generics. And almost everybody considers generic drugs a no-brainer. You get significant savings without any (noticeable) change in your treatment. But they're not epileptic. And they don't walk the tightrope of a delicate neurological balance. True, with most medications, there's only a subtle change between a brand-name drug and a generic. And usually, the two drugs can be switched without any side effects. However, with anti-epileptic drugs (AEDs), there can be as much as a 20% difference between the absorption and metabolization of the drugs. Which can effect seizure control and even lead to breakthrough seizures.
Comment Wall (1 comment)
Guess what? Those Brain C-13 Review increasing co-pays for brand-name drugs don't exactly thrill the insurance industry either. And pharmacies have a much lower profit margin with brand-name drugs versus profitable generics. And almost everybody considers generic drugs a no-brainer. You get significant savings without any (noticeable) change in your treatment. But they're not epileptic. And they don't walk the tightrope of a delicate neurological balance. True, with most medications, there's only a subtle change between a brand-name drug and a generic. And usually, the two drugs can be switched without any side effects. However, with anti-epileptic drugs (AEDs), there can be as much as a 20% difference between the absorption and metabolization of the drugs. Which can effect seizure control and even lead to breakthrough seizures.
https://healthadviserpro.com/brain-c-13-review/
You need to be a member of Wane Enterprises to add comments!
Join Wane Enterprises